Anti-HIF-2-alpha antibody [BL-95-1A2]
- Advanced Validation
- Recombinant
- 각 태그의 뜻
1
(1 리뷰)
|
(15 제품이 사용된 논문 )
Anti-HIF-2-alpha antibody [BL-95-1A2] (ab243861) is a rabbit monoclonal antibody detecting HIF-2-alpha in Western Blot, IP, IHC-P, ICC/IF, ChIP-seq. Suitable for Human.
- Recombinant format for unrivalled batch-batch consistency
대체 명칭 보기
BHLHE73, HIF2A, MOP2, PASD2, EPAS1, Endothelial PAS domain-containing protein 1, EPAS-1, Basic-helix-loop-helix-PAS protein MOP2, Class E basic helix-loop-helix protein 73, HIF-1-alpha-like factor, Hypoxia-inducible factor 2-alpha, Member of PAS protein 2, PAS domain-containing protein 2, bHLHe73, HLF, HIF-2-alpha, HIF2-alpha
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HIF-2-alpha antibody [BL-95-1A2] (AB243861)
Formalin-fixed, paraffin-embedded human renal cell carcinoma tissue stained for HIF-2 alpha using ab243861 at 1/400 dilution in immunohistochemical analysis. A HRP-conjugated goat anti-rabbit IgG was used as the secondary. DAB staining.
- ICC
Unknown
Immunocytochemistry - Anti-HIF-2-alpha antibody [BL-95-1A2] (AB243861)
Formalin-fixed, paraffin-embedded HepG2 (human liver hepatocellular carcinoma cell line) cells labeling HIF-2 alpha using ab243861 at 1/400 dilution in ICC/IF analysis. A HRP-conjugated goat-anti rabiit IgG was used as the secondary. DAB staining.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-HIF-2-alpha antibody [BL-95-1A2] (AB243861)
Formaldehyde-fixed HepG2 (human liver hepatocellular carcinoma cell line) cells untreated (Left) and treated with CoCl2 (right), labeling HIF-2 alpha (Red) using ab243861 at 1/100 dilution. DyLight® 594-conjugated goat anti-rabbit IgG was used as the secondary antibody at 1/100 dilution. Phalloidin Alexa Fluor® 488conjugated (green) was used as the counterstain.
- IP
Unknown
Immunoprecipitation - Anti-HIF-2-alpha antibody [BL-95-1A2] (AB243861)
HIF-2 alpha was immunoprecipitated from 1 mg HepG2 whole cell lysate with ab243861 at 20 μL per reaction. Western blot was performed on the immunoprecipitate using ab243861 at 1/1000 dilution. Lane 1 : ab243861 IP in HepG2 cell lysate treated with 200 μM CoCl2.
Lane 2 : ab243861 IP in HepG2 whole cell lysate Mock treated.
Lane 3 : Contol IgG in HepG2 cell lysate treated with 200 μM CoCl2.
All lanes:
Immunoprecipitation - Anti-HIF-2-alpha antibody [BL-95-1A2] (ab243861)
Predicted band size: 96 kDa
false
- ChIP-seq
Unknown
ChIP-sequencing - Anti-HIF-2-alpha antibody [BL-95-1A2] (AB243861)
Chromatin from subcutaneous human tumor 786-O cells was immunoprecipitated with anti-HIF-2-alpha antibody ab243861 and analyzed by
DNA sequencing. The figure illustrates the peak distribution of HIF-2-alpha binding within a 250 Kb region of chromosome 11 as detected
using anti-HIF-2-alpha antibody ab243861. ChIP-seq validation performed by Active Motif, Carlsbad, CA.
- WB
Unknown
Western blot - Anti-HIF-2-alpha antibody [BL-95-1A2] (AB243861)
All lanes:
Western blot - Anti-HIF-2-alpha antibody [BL-95-1A2] (ab243861) at 1/1000 dilution
Lane 1:
HepG2 whole cell lysate treated with 200uM CoCl2 at 15 µg
Lane 2:
HepG2 whole cell lysate mock treated at 15 µg
Lane 3:
HEK293T whole cell lysate treated with 200uM CoCl2 at 15 µg
Lane 4:
HEK293T whole cell lysate mock treated at 15 µg
Lane 5:
786-O whole cell lysate mock treated at 15 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG
Predicted band size: 96 kDa
false
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-HIF-2-alpha antibody [BL-95-1A2] - BSA free
Reactivity 정보
제품 세부 정보
What is this antibody validated in?
Anti-HIF-2-alpha antibody [BL-95-1A2] (ab243861) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF), ChIP in Human samples.
Other related products
We have a range of other formats of antibody clone [BL-95-1A2] also available for your convenience: ab243861, ab272041
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
This product is sold under License from Bethyl Laboratories, Inc.
특성 및 보관 정보
제형
Purification 관련 사항
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HIF-2-alpha regulates the expression of genes involved in energy metabolism and angiogenesis. The protein forms a complex by dimerizing with the HIF-1-beta subunit which is necessary for transcriptional activity. Through this complex formation and activity it influences processes such as erythropoiesis and regulates factors like vascular endothelial growth factor (VEGF). Therefore HIF-2-alpha contributes to the adaptation of cells and tissues under hypoxic conditions.
Pathways
HIF-2-alpha engages in the hypoxia signaling pathway playing an essential part by modulating gene expression in response to low oxygen availability. This role impacts other proteins such as HIF-1-alpha sharing overlapping functions but with distinct target genes. Additionally HIF-2-alpha is involved in the mTOR pathway which influences cell growth and metabolism through its interaction with the nutrient-sensing regulatory pathway.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
제품이 사용된 논문 (15)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Cell death & disease 16:312 PubMed40246814
2025
Applications
Unspecified application
Species
Unspecified reactive species
Anticancer research 45:639-650 PubMed39890197
2025
Applications
Unspecified application
Species
Unspecified reactive species
BJC reports 2:10 PubMed39516578
2024
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 20:e1011998 PubMed38530845
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 51: PubMed38391012
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 21:882 PubMed38057853
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 21:220 PubMed36967443
2023
Applications
Unspecified application
Species
Unspecified reactive species
Anti-cancer agents in medicinal chemistry 23:807-816 PubMed36028958
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:463 PubMed35568711
2022
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 118: PubMed34706936
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com